Lower-extremity amputation in people with diabetes. Epidemiology and prevention
- PMID: 2714164
- DOI: 10.2337/diacare.12.1.24
Lower-extremity amputation in people with diabetes. Epidemiology and prevention
Abstract
The age-adjusted rate of lower-extremity amputation (LEA) in the diabetic population is approximately 15 times that of the nondiabetic population. Over 50,000 LEAs were performed on individuals with diabetes in the United States in 1985. Among individuals with diabetes, peripheral neuropathy and peripheral vascular disease (PVD) are major predisposing factors for LEA. Lack of adequate foot care and infection are additional risk factors. Several large clinical centers have experienced a 44-85% reduction in the rate of amputations among individuals with diabetes after the implementation of improved foot-care programs. Programs to reduce amputations among people with diabetes in primary-care settings should identify those at high risk; clinically evaluate individuals to determine specific risk status; ensure appropriate preventive therapy, treatment for foot problems, and follow-up; provide patient education; and, when necessary, refer patients to specialists, including health-care professionals for diagnostic and therapeutic interventions and shoe fitters for proper footwear. Programs should monitor and evaluate their activities and outcomes. Many issues related to the etiology and prevention of LEAs require further research.
Similar articles
-
Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.Diabetes Care. 1999 Jul;22(7):1029-35. doi: 10.2337/diacare.22.7.1029. Diabetes Care. 1999. PMID: 10388962
-
Must loss of limb be a consequence of diabetes mellitus?Diabetes Care. 1979 Sep-Oct;2(5):432-6. doi: 10.2337/diacare.2.5.432. Diabetes Care. 1979. PMID: 510144 No abstract available.
-
Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention.Diabetes Care. 2004 Nov;27(11):2636-41. doi: 10.2337/diacare.27.11.2636. Diabetes Care. 2004. PMID: 15504998
-
The diabetic foot: amputations and drainage of infection.J Vasc Surg. 1987 May;5(5):791-3. doi: 10.1067/mva.1987.avs0050791. J Vasc Surg. 1987. PMID: 3553624 Review.
-
Diabetic foot.N Y State J Med. 1973 Dec 1;73(23):2778-81. N Y State J Med. 1973. PMID: 4358484 Review. No abstract available.
Cited by
-
Change in amputation predictors in diabetic foot disease: effect of multidisciplinary approach.Endocrine. 2010 Aug;38(1):87-92. doi: 10.1007/s12020-010-9355-z. Epub 2010 Jun 20. Endocrine. 2010. PMID: 20960107
-
The role of reconstructive microsurgery in treating lower-extremity chronic wounds.Int Wound J. 2019 Aug;16(4):951-959. doi: 10.1111/iwj.13127. Epub 2019 May 30. Int Wound J. 2019. PMID: 31148396 Free PMC article.
-
The pro-inflammatory environment in recalcitrant diabetic foot wounds.Int Wound J. 2008 Oct;5(4):530-9. doi: 10.1111/j.1742-481X.2008.00457.x. Int Wound J. 2008. PMID: 19006574 Free PMC article. Review.
-
Cost-effective management of diabetic foot ulcers. A review.Pharmacoeconomics. 1997 Jul;12(1):42-53. doi: 10.2165/00019053-199712010-00005. Pharmacoeconomics. 1997. PMID: 10173073 Review.
-
Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia.Cost Eff Resour Alloc. 2024 Nov 18;22(1):84. doi: 10.1186/s12962-024-00591-8. Cost Eff Resour Alloc. 2024. PMID: 39558204 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical